#SOLO2

top of page

it's where dermatology lives

DERM. CITY 2 copy.png

5. 3822-EN_Square post-1260x126px_V02.jpg

Yellow & Black gradient online health services linkedin banner (2000 x 400 px).gif

By John Evans, Associate Editor, Derm.city

Jul 11, 20174 min read

Trials show dupilumab effective, safe for moderate to severe AD

The SOLO 1 and SOLO 2 phase 3 trials of the human monoclonal anti-body dupilumab for the treatment of eczema/atopic dermatitis (AD) have...

Featured Posts

Nominations for the 2024 Women in Dermatology Honour Roll closing soon

Invitation to participate: Skin of Colour nomenclature survey study

All Posts 1,441 postsNo categories yet.
General 226 postsNo categories yet.
Acne 43 postsNo categories yet.
Videos 354 postsNo categories yet.
News 392 postsNo categories yet.
Atopic Dermatitis 152 postsNo categories yet.
Psoriasis 151 postsNo categories yet.
Skin Cancer 198 postsNo categories yet.
Melasma 2 postsNo categories yet.
Patient care 62 postsNo categories yet.
Cosmetic 28 postsNo categories yet.
Rosacea 10 postsNo categories yet.
Skin Spectrum Summit 49 postsNo categories yet.
Clinical Practice 10 postsNo categories yet.

600x100 animated.gif

bottom of page